HUP-46

N/A

Report date: 2025/01/26 18:04:39
NME

Base Information

Drug NameHUP-46
Drug Alias NameHUP-46
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProlyl endopeptidase inhibitors
TargetsProlyl endopeptidase
Therapy Area/IndicationsFrontotemporal DementiaAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Eastern Finland
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsFrontotemporal DementiaAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A